Prolonged inhibition of factor Xa with SanOrg-34006 provides high patency rate after thrombolysis July 10, 2001
Factor Xa-selective anticoagulant DPC-423 has oral bioavailability and antithrombotic activity July 10, 2001
Direct-acting factor Xa inhibitor PD-198961 shows promise for both arterial and venous thrombosis July 10, 2001
Licensing opportunity from NIH: mutations applicable for development of dengue vaccines July 10, 2001
RSS